SIM
TPST icon

Spark Investment Management’s Tempest Therapeutics TPST Stock Holding History

Spark Investment Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11
Closed -$1.12M – 735
2015
Q1 		$1.12M Buy
+11
New +$1.46M 0.16% 215
2014
Q4 		– Sell
-10
Closed -$484K – 798
2014
Q3 		$484K Buy
+10
New +$351K 0.07% 361
2014
Q2 		– Sell
-7
Closed -$180K – 732
2014
Q1 		$180K Buy
+7
New +$198K 0.03% 539

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OH
Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Spark Investment Management's TPST Position: Q2 2015 in Review

Spark Investment Management sold out of Tempest Therapeutics (TPST) in Q2 2015, closing a stake of 11 shares — an estimated $1.12M sold.

Spark Investment Management first reported a position in TPST in Q1 2014 and held it in 3 quarters. The position peaked at $1.12M in Q1 2015. 92 funds tracked by Wall St. Rank hold TPST as of Q2 2015.

  • Spark Investment Management reported no remaining Tempest Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 11 Tempest Therapeutics shares in Q2 2015, an estimated $1.12M.
  • Spark Investment Management first reported a position in Tempest Therapeutics in Q1 2014 and held it in 3 quarters.
  • Spark Investment Management's Tempest Therapeutics position peaked at $1.12M in Q1 2015.
  • 92 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.